Group 6 Copy 49
0
    Please wait...

    About This Project

    OncoSynergy, Inc.
    The Ebola outbreak in west Africa has been declared a global emergency by the WHO with over 1,000 victims and no approved therapies. OncoSynergy is developing a readily manufactured experimental cancer drug, OS2966, which coincidentally targets the receptor hijacked by ebola to infect cells. This project aims to demonstrate that OS2966 inhibits ebola infection of human cells thus providing the impetus for expediting OS2966 for treatment of ebola.
    Blast off!

    Browse Other Projects on Experiment

    Related Projects

    Is Plastic a Chronic Killer? Calculating the Toxicity of Plastic Ingestion to Sea Turtles.

    What are the toxic and ecological effects of marine plastic pollution to sea turtles? This research aims to...

    Barcoding Alaska

    We want to DNA barcode plants of the Alaskan wild with the help of citizen scientists and local Brooklyn...

    Backer Badge Funded

    A biology project funded by 47 people